CAMBRIDGE ONCOMETRIX
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer - a condition that affects 1 in 7 men on the planet. The company develops a non-invasive risk stratification test for prostate cancer. The laboratory test will be capable of accurately selecting men for mpMRI-guided biopsy.
CAMBRIDGE ONCOMETRIX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2012-06-12
Address:
Haverhill, Suffolk, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cambridgeoncometrix.com
Total Employee:
1+
Status:
Active
Contact:
+441603 274 521
Email Addresses:
[email protected]
Total Funding:
1.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Mobile Non Scaleable Content GoDaddy LiteSpeed CPanel Wix DNS Krystal Hosting
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
i4i-connect
i4i-connect investment in Grant - Cambridge Oncometrix
SBRI Healthcare
SBRI Healthcare investment in Grant - Cambridge Oncometrix
Anglia Capital Group
Anglia Capital Group investment in Seed Round - Cambridge Oncometrix
SBRI Healthcare
SBRI Healthcare investment in Grant - Cambridge Oncometrix
MassChallenge
MassChallenge investment in Non Equity Assistance - Cambridge Oncometrix
Pitch@Palace
Pitch@Palace investment in Non Equity Assistance - Cambridge Oncometrix
Newest Events participated
Official Site Inspections
http://www.cambridgeoncometrix.com
- Host name: 199.59.243.227
- IP address: 199.59.243.227
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago